Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment

Name: Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
Published: 2016
License: Public Domain

Memorial Sloan Kettering Cancer Center · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

leukemia lymphoma

solid tumor, central nervous system tumor, lymphoma, leukemia, recurrent, refractory disease, neratinib, 16-878, interventional, phase1, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment

Related documents